



Markets
/
Stocks
/
nasdaq-biib
/

Biogen Inc

BIIB

View Detailed Chart

121.080USD

+0.909+0.76%

Close 04/30, 16:00（ET）Quotes delayed by 15 min

17.64BMarket Cap

10.81P/E TTM



Biogen Inc

121.080

+0.909+0.76%

Company

Intraday

30m

Today

+0.76%

5 Days

+2.46%

1 Month

-11.67%

6 Months

-30.41%

Year to Date

-20.82%

1 Year

-43.64%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 37 analysts

BUY

Current Rating

180.153

Target Price

49.92%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

162

Total

Median

Average

Company name

Ratings

Analysts

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Amgen Inc

AMGN

Alnylam Pharmaceuticals Inc

ALNY

Gilead Sciences Inc

GILD

BioMarin Pharmaceutical Inc

BMRN

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(4)

Neutral(4)

Buy(3)

Indicators

Sell(1)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

2.229

Neutral

RSI(14)

42.801

Neutral

STOCH(KDJ)(9,3,3)

70.955

Neutral

ATR(14)

4.545

Low Volatility

CCI(14)

89.943

Neutral

Williams %R

13.487

Overbought

TRIX(12,20)

-0.636

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

119.162

Buy

MA10

118.207

Buy

MA20

120.033

Buy

MA50

133.747

Sell

MA100

147.539

Sell

MA200

178.337

Sell

News

More news coming soon, stay tuned...

Company

Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).

Company codeBIIB

CompanyBiogen Inc

CEOMr. Christopher A. (Chris) Viehbacher

Websitehttps://www.biogen.com/